Total trials
826
Active
197
Phase 3
27
Total enrollment
275,114
Pipeline matrix
Showing 40 of 111 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Liraglutide | — | — | — | — | — | 3 | |
| Tirzepatide | — | — | — | — | — | 1 | |
| Nicorette | — | — | — | — | — | 1 | |
| Niraparib | — | — | — | — | — | 1 | |
| Collagenase Clostridium Histolyticum | — | — | — | — | — | 1 | |
| Fluzone Quadrivalent | — | — | — | — | — | 1 | |
| Albuterol Sulfate | — | — | — | — | — | 1 | |
| Albuterol-Budesonide | — | — | — | — | — | 1 | |
| Testosterone cypionate | — | — | — | — | — | 1 | |
| Anti Arrhythmics | — | — | — | — | — | 1 | |
| Triamcinolone 10 Mg/mL Injectable Suspension | — | — | — | — | — | 1 | |
| Triamcinolone 40 Mg/mL Injectable Suspension | — | — | — | — | — | 1 | |
| Triamcinolone 80 Mg/mL Injectable Suspension | — | — | — | — | — | 1 | |
| Dexamethasone 2 MG | — | — | — | — | — | 1 | |
| Dexamethasone 4mg | — | — | — | — | — | 1 | |
| Dexamethasone 8 MG | — | — | — | — | — | 1 | |
| Standard dose influenza vaccination | — | — | — | — | — | 1 | |
| High dose influenza vaccination | — | — | — | — | — | 1 | |
| Duloxetine | — | — | — | — | — | 1 | |
| PYTEST® 14C-Urea Breath Test | — | — | — | — | — | 1 | |
| VOQUEZNA® Triple Pak® | — | — | — | — | — | 1 | |
| PYTEST® 14C-Urea Capsule Breath Test | — | — | — | — | — | 1 | |
| Bactrim | — | — | — | — | — | 1 | |
| Magnesium Threonate | — | — | — | — | — | 1 | |
| Vitamin D3 | — | — | — | — | — | 1 | |
| tadalafil | — | — | — | — | — | 1 | |
| ZYNRELEF 400Mg-12Mg Extended-Release Solution | — | — | — | — | — | 1 | |
| Ropivacaine 0.5% Injectable Solution | — | — | — | — | — | 1 | |
| Durysta, Bimatoprost Intracameral Implant 10 µg | — | — | — | — | — | 1 | |
| Perineal ice packs, medicated witch-hazel pads, and topical benzocaine spray | — | — | — | — | — | 1 | |
| Diphenhydramine | — | — | — | — | 2 | ||
| Cetirizine | — | — | — | — | — | 1 | |
| Probenecid 500 Milligrams | — | — | — | — | — | 1 | |
| probenecid 250 Milligrams | — | — | — | — | — | 1 | |
| Dexamethasone | — | — | — | 6 | |||
| Acetaminophen | — | — | — | 5 | |||
| Leucovorin | — | — | — | — | 8 | ||
| Pembrolizumab | — | — | — | — | — | 4 | |
| Irinotecan | — | — | — | — | 3 | ||
| 5-Fluorouracil | — | — | — | — | 2 |
71 more active programs hidden
Next readouts
- 2026-06-30
- 2026-07-31
- 2026-07-31
- 2026-09-30
- 2026-09-30
- 2026-09-30
- 2026-09-30
- 2026-10-31
- 2026-11-01
- 2026-12-01
Top conditions
- Depression22
- Prostate Cancer20
- Obesity18
- Spinal Cord Injury18
- Breast Cancer18
- Spinal Cord Injuries17
- Head and Neck Cancer12
- HIV12
Frequently asked questions about University of Miami
- How many clinical trials does University of Miami have on ClinicalTrials.gov?
- University of Miami is listed as the lead sponsor on 826 clinical trials in ClinicalTrials.gov, 197 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Miami's trials are in Phase 3?
- 27 of University of Miami's trials are in Phase 3, spread across 111 active drug programs.
- What therapeutic areas does University of Miami focus on?
- University of Miami's most-studied conditions on ClinicalTrials.gov are Depression, Prostate Cancer, Obesity, Spinal Cord Injury, Breast Cancer.
- When are University of Miami's next clinical trial readouts?
- University of Miami has 10 upcoming primary-completion readouts tracked here; the soonest is “Tfh Dysfunction in HIV and Aging”, expected around 2026-06-30.